6505--Radiopharmaceuticals Nuclear Med Columbus

This is a SOURCES SOUGHT notice. Please note that this is not a request for quotes (RFQ) or bids, and the government is seeking information for market research purposes only. No solicitation document is available. The Department of Veterans Affairs, Network Contracting Office (NCO) 10 is issuing this Sources Sought to identify potential experienced businesses that are capable of meeting the requirements per the Statement of Work (SOW) below. The response to this notice shall be in summary format and shall not exceed two (2) pages. Please include the following:

Contractor shall also comply with any other federal, state, and local laws applicable to the industry. Potential sources must demonstrate experience, and knowledge of required services and capability to provide such services. Potential sources should submit:

Business name and address,

Point of contact,

DUNS Number

Business size, and any applicable business socio-economic category

Capabilities Statement to include at a minimum the following information:

Do you currently or have you had past experience providing Radiopharmaceuticals to the Department of Veterans Affairs? If so, how many VA Medical Centers did you support concurrently within a single contract? Which VISN?

Demonstrate your company s experience with supporting VA Medical Centers with Radiopharmaceuticals.

Demonstrated your company s ability to obtain and maintain required Nuclear Regulatory Commission (NRC) certifications.

Demonstrate your capabilities to provide or acquire the necessary resources (i.e., personnel, facilities, materials, transportation, equipment and communication services) to provide the required Radiopharmaceuticals.

Please indicate if your company can provide services for the Chalmers P. Wylie Ambulatory Care Center, Columbus, OH.

No basis for claim against the Government shall arise as a result of a response to this sources sought, or Government use of any information provided. The Government will not pay for information or comments provided and will not recognize any costs associated with submission of comments. There is no guarantee, expressed or implicit, that market research for this acquisition will result in a particular set-aside or sole source award, or any other guarantee of award or acquisition strategy.

Responses to this notice shall be e-mailed to Gina.crank@va.gov. Telephone responses will not be accepted. Responses must be received in writing no later than 5:00 p.m., Wednesday, November 30, 2022. This notice is to assist the VA in determining sources only. THE VA IS NOT CURRENTLY SEEKING PRICING OR OFFERS OF ANY KIND. There is no guarantee, expressed or implicit, that the market research for this acquisition will result in a particular guarantee of award strategy. All information is to be provided on a voluntary basis at no charge to the Government.

STATEMENT OF WORK (SOW)

The Columbus VA Ambulatory Care Center (VAACC), Columbus OH has a requirement for unit dose preparation of radiopharmaceuticals for patient care. The Contractor is to provide unit dose Radiopharmaceutical products, per patient order, as listed herein, as requested by authorized VA Staff, in accordance with Public Law 104-262 and 38 USC 8153 in order to support the VAACC, Columbus OH. Because we do not have the capacity to compound these radiopharmaceuticals in our facility (per USP 797 and USP 825), we are contracting the service of providing the compounding on a unit dose basis, to be delivered to nuclear medicine, calibrated to the proper amount at the proper time, per patient (by physician order), as ordered by 4 pm the day before.

DELIVERIES: Deliveries to VAACC Columbus shall be made to:

Chalmers P. Wylie VA Ambulatory Care Center

Nuclear Medicine Service

420 North James Rd.

Columbus, OH, 43219.

Contractor shall provide routine delivery of items during the hours of 7:30 a.m. to 4:00 p.m., Monday through Friday, excluding holidays. It is anticipated that routine deliveries will be made once or twice daily at 8:00 a.m. and as needed.

All routine deliveries of unit doses per patient, ordered by 4:30 p.m. the previous day, shall be at the VA facility by 8:00 a.m. the next business day. The order shall include the patient name and prescribed radiopharmaceutical.

Emergency and additional request orders may be made and shall be delivered within 45 minutes and one (1) hour of placement of the order, during our normal business hours ( 7:30am to 4:00 pm).

Pre-calibrated doses should not expire within 1 hours of calibration time requested by the Nuclear Medicine Service.

Stat Orders (emergency doses ordered during normal business hours: 7:30 a.m. 4:00 p.m.) shall be delivered within one (1) hour of placement of the order.

The 11 Federal Holidays observed by the Federal Government are:

New Year s Day January 1

Martin Luther King s Birthday 3rd Monday in January

Presidents Day 3rd Monday in February

Memorial Day Last Monday in May

Juneteenth June 19

Independence Day July 4

Labor Day 1st Monday in September

Columbus Day 2nd Monday in October

Veterans Day November 11

Thanksgiving Day 4th Thursday in November

Christmas Day December 25th

The President of the United States of America may declare additional days as a Federal holiday, and if so, this holiday will automatically be added to the list above. When a holiday falls on a Sunday, the following Monday shall be observed as a Federal holiday. When a holiday falls on a Saturday, the preceding Friday shall be observed as a Federal Holiday.

All doses provided under this contract shall meet all requirements of the Nuclear Regulatory Commission (NRC). All doses provided under this contract shall be packaged and shipped in accordance with the requirements of the NRC and Department of Transportation (DOT). All products returned will also be packaged in accordance with the requirements of the NRC and DOT. All doses will be dispensed for the specific amount required for the physician prescribed testing, unless special arrangements are made.

Compliance with all OSHA manufacturing, packaging and shipping regulations is required.

The contractor shall guarantee the quality of all radiopharmaceuticals. Quality control shall include percent tag and MO99 breakthrough as appropriate. The Contractor shall provide Quality Control on each agent dispensed, on request. The Contractor shall guarantee the quality of all doses of radiopharmaceuticals. The Contractor shall provide complete documentation on Quality Control results upon request.

The Contractor shall provide documentation of inventory, disposal and patient dose records, which documents compliance with Nuclear Regulatory Commission (NRC).

The Contractor shall provide complete documentation on inventory, disposal and patient dose records upon request.

RECALLED AND DEFECTIVE PRODUCTS: the Contractor will immediately notify the nuclear medicine department, followed by the Contracting Officer, of any recalls of product or other important product safety issues. As appropriate, the Contractor will replace and/or reimburse recalled / defective products at no cost to the Government. The Contractor may be liable for costs of processing recalls, i.e., administrative and clinical services to replace recalled / defective products.

Cost/Price Schedule

The quantities listed below are yearly estimates only and do not guarantee that the Government will require the total quantities of each item.

BASE YEAR January 6, 2023 January 5, 2024

Item

Est. Qty

Price Per

Total Price

99M TC Sulfur Colloid: 1 to 6 Millicurie

26

99M TC-MAA: 5 Millicurie

1

99M Tc-HDP: 25 Millicuries

170

99M Tc Mebrofenin: 5 to 15 Millicuries

50

99M TC-MAG-3 unit dose: 20 Millicurie

5

99M Tc-Sestamibi (generic): 10 to 35 millicurie

1200

Gallium-67: 1 Millicurie

1

201-THALLIUM CHLORIDE: 1 Millicurie

1

IN-111 OCTREOTIDE: 2 to 7 Millicurie

5

99M TC-White Blood Cells: 25 Millicurie

2

99M TC-O 4: 25 Millicurie

6

99M TC Sources

10

99m Tc- Linearity doses

4

IN-111 White Blood Cells: per study (0.5 to 1 millicurie)

10

ULTRATAG KIT

6

Filtered Sulfur Colloid

12

OPTION YEAR ONE (1) January 6, 2024 January 5, 2025

Item

Est Qty

Price Per

Total Price

99M TC Sulfur Colloid: 1 to 6 Millicurie

26

99M TC-MAA: 5 Millicurie

1

99M Tc-HDP: 25 Millicuries

170

99M Tc Mebrofenin: 5 to 15 Millicuries

50

99M TC-MAG-3: 20 Millicurie

5

99M Tc-Sestamibi (generic): 10 to 35 millicurie

1200

Gallium-67: 1 Millicurie

1

201-THALLIUM CHLORIDE: 1 Millicurie

1

IN-111 OCTREOTIDE: 2 to 7 Millicurie

5

99M TC-White Blood Cells: 25 Millicurie

2

99M TC-O 4: 25 Millicurie

6

99M TC Sources

10

99m Tc- Linearity doses

4

IN-111 White Blood Cells: per study (0.5 to 1 millicurie)

10

ULTRATAG KIT

6

99M TC Sulfur Colloid: 1 to 6 Millicurie

26

99M TC-MAA: 5 Millicurie

1

99M Tc-HDP: 25 Millicuries

170

99M Tc Mebrofenin: 5 to 15 Millicuries

50

99M TC-MAG-3 unit dose: 20 Millicurie

5

99M Tc-Sestamibi (generic): 10 to 35 millicurie

1200

Gallium-67: 1 Millicurie

1

201-THALLIUM CHLORIDE: 1 Millicurie

1

Filtered Sulfur Colloid

12

OPTION YEAR TWO (2) January 6, 2025 January 5, 2026

Item

Est Qty

Price Per

Total Price

99M TC Sulfur Colloid: 1 to 6 Millicurie

26

99M TC-MAA: 5 Millicurie

1

99M Tc-HDP: 25 Millicuries

170

99M Tc Mebrofenin: 5 to 15 Millicuries

50

99M TC-MAG-3: 20 Millicurie

5

99M Tc-Sestamibi (generic): 10 to 35 millicurie

1200

Gallium-67: 1 Millicurie

1

201-THALLIUM CHLORIDE: 1 Millicurie

1

IN-111 OCTREOTIDE: 2 to 7 Millicurie

5

99M TC-White Blood Cells: 25 Millicurie

2

99M TC-O 4: 25 Millicurie

6

99M TC Sources

10

99m Tc- Linearity doses

4

IN-111 White Blood Cells: per study (0.5 to 1 millicurie)

10

ULTRATAG KIT

6

99M TC Sulfur Colloid: 1 to 6 Millicurie

26

99M TC-MAA: 5 Millicurie

1

99M Tc-HDP: 25 Millicuries

170

99M Tc Mebrofenin: 5 to 15 Millicuries

50

99M TC-MAG-3: 20 Millicurie

5

99M Tc-Sestamibi (generic): 10 to 35 millicurie

1200

Gallium-67: 1 Millicurie

1

Filtered Sulfur Colloid

12

Â

OPTION YEAR THREE (3) January 6, 2026 January 5, 2027

Item

Est Qty

Price Per

Total Price

99M TC Sulfur Colloid: 1 to 6 Millicurie

26

99M TC-MAA: 5 Millicurie

1

99M Tc-HDP: 25 Millicuries

170

99M Tc Mebrofenin: 5 to 15 Millicuries

50

99M TC-MAG-3: 20 Millicurie

5

99M Tc-Sestamibi (generic): 10 to 35 millicurie

1200

Gallium-67: 1 Millicurie

1

201-THALLIUM CHLORIDE: 1 Millicurie

1

IN-111 OCTREOTIDE: 2 to 7 Millicurie

5

99M TC-White Blood Cells: 25 Millicurie

2

99M TC-O 4: 25 Millicurie

6

99M TC Sources

10

99m Tc- Linearity doses

4

IN-111 White Blood Cells: per study (0.5 to 1 millicurie)

10

ULTRATAG KIT

6

99M TC Sulfur Colloid: 1 to 6 Millicurie

26

99M TC-MAA: 5 Millicurie

1

99M Tc-HDP: 25 Millicuries

170

99M Tc Mebrofenin: 5 to 15 Millicuries

50

99M TC-MAG-3: 20 Millicurie

5

99M Tc-Sestamibi (generic): 10 to 35 millicurie

1200

Gallium-67: 1 Millicurie

1

Filtered Sulfur Colloid

12

OPTION YEAR FOUR (4) January 6, 2027 January 5, 2028

Item

Est Qty

Price Per

Total Price

99M TC Sulfur Colloid: 1 to 6 Millicurie

26

99M TC-MAA: 5 Millicurie

1

99M Tc-HDP: 25 Millicuries

170

99M Tc Mebrofenin: 5 to 15 Millicuries

50

99M TC-MAG-3: 20 Millicurie

5

99M Tc-Sestamibi (generic): 10 to 35 millicurie

1200

Gallium-67: 1 Millicurie

1

201-THALLIUM CHLORIDE: 1 Millicurie

1

IN-111 OCTREOTIDE: 2 to 7 Millicurie

5

99M TC-White Blood Cells: 25 Millicurie

2

99M TC-O 4: 25 Millicurie

6

99M TC Sources

10

99m Tc- Linearity doses

4

IN-111 White Blood Cells: per study (0.5 to 1 millicurie)

10

ULTRATAG KIT

6

99M TC Sulfur Colloid: 1 to 6 Millicurie

26

99M TC-MAA: 5 Millicurie

1

99M Tc-HDP: 25 Millicuries

170

99M Tc Mebrofenin: 5 to 15 Millicuries

50

99M TC-MAG-3: 20 Millicurie

5

99M Tc-Sestamibi (generic): 10 to 35 millicurie

1200

Gallium-67: 1 Millicurie

1

Filtered Sulfur Colloid

12

Total Base plus Option Years

Â